Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA

OBJECTIVE: Type 1 diabetes (T1D) progression is affected by circulating glutamic acid decarboxylase antibody (GADA) that persist for many years. This study aimed at investigating whether and how the gut microbiome and its correlated metabolites change in T1D with the presence of GADA. METHODS: We us...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Sihui, Yue, Tong, Liu, Ziyu, Yang, Daizhi, Xu, Mengyun, Ding, Yu, Jiang, Weiwei, Xu, Wen, Yan, Jinhua, Weng, Jianping, Zheng, Xueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563112/
https://www.ncbi.nlm.nih.gov/pubmed/36246882
http://dx.doi.org/10.3389/fendo.2022.938358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563112/
https://www.ncbi.nlm.nih.gov/pubmed/36246882
http://dx.doi.org/10.3389/fendo.2022.938358

Ejemplares similares